AveXis

Dallas – October 14, 2026 -- Nanoscope Therapeutics has appointed Troy Short, who built the global supply chain for Zolgensma across more than 30 countries at AveXis, as Senior Vice President of Manufacturing and Supply Chain while its lead gene therapy MOGENRY is under regulatory review in the United States and Japan.

Short takes charge of GMP manufacturing, commercial supply and global distribution

Short will lead Nanoscope's GMP manufacturing, commercial supply and global distribution strategy as the company moves toward potential approval and launch of MOGENRY (sonpiretigene isteparvovec; MCO-010). He has more than 20 years of operations and supply chain experience in pharmaceuticals and gene therapy.

His stated priorities are strengthening manufacturing partnerships, building a resilient commercial supply chain and ensuring product availability to patients and physicians upon potential approval.